Surgical therapy of primary cutaneous melanoma

Seminars in Surgical Oncology

Volumn 12, Issue 6, 1996, Pages 386-393

  Geraghty, Patrick J ^a   Johnson, Timothy M ^a   Sondak, Vernon K ^a   Chang, Alfred E ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

biopsy methods; melanoma; neoplasm recurrence, local; prognosis; prospective studies; randomized controlled trials; skin neoplasm surgery; surgery, operative methods

Indexed keywords

CANCER LOCALIZATION; CANCER RECURRENCE; CANCER STAGING; CLINICAL TRIAL; FOLLOW UP; HUMAN; MELANOMA; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SKIN BIOPSY; SKIN INCISION; SURGICAL TECHNIQUE; TREATMENT OUTCOME; TREATMENT PLANNING;

BIOPSY; FOLLOW-UP STUDIES; FOOT; HAND; HEAD AND NECK NEOPLASMS; HUMANS; LYMPHATIC METASTASIS; MELANOMA; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS; SKIN NEOPLASMS; THUMB; TIME FACTORS; TOES;

EID: 0029805786     PISSN: 87560437     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2388(199611/12)12:6<386::AID-SSU3>3.0.CO;2-6     Document Type: Review

References (33)

1. Johnson TM. Smith JW II, Nelson BR, Chang AE: Current therapy for cutaneous melanoma. J Am Acad Dermatol 32 [5 Pt 1 ]:698-707, 1995.
2. Urist MM, Karnell LH: The National Cancer Data Base. Report on melanoma. Cancer 74:783-788, 1994.
3. Lederman JS. Sober AJ: Does biopsy type influence survival in clinical stage I cutaneous melanoma? J Am Acad Dermatol 13:983-987, 1985.
4. Balch CM, Murad TM, Soong SJ, et al: A multifactorial analysis of melanoma: prognostic histopathological features comparing Clark's and Breslow's staging methods. Ann Surg 188:732-742, 1978.
5. Harris TJ, Rigel DS, Day CL Jr, et al: "Microscopic satellites" are more highly associated with regional lymph node metastasis than is primary melanoma thickness. Cancer 53:2183-2187, 1984.
6. Kelly JW, Sagebiell RW, Calderon W, et al: The frequency of local recurrence and microsatellites as a guide to reexcision margins for cutaneous melanoma. Ann Surg 200:759-763, 1984.
7. Urist MM, Balch CM, Soong SJ. et al: The influence of surgical margins and prognostic factors predicting the risk of local recurrence in 3445 patients with primary cutaneous melanoma. Cancer 55:1398-1402, 1985.
8. Pontikes LA, Temple WJ, Cassar SL, et al: Influence of level and depth on recurrence rate in thin melanomas. Am J Surg 165: 225-228, 1993.
9. Mansson-Brahme E, Carstensen J, Erhardt K, et al: Prognostic factors in thin cutaneous malignant melanoma. Cancer 73:2324-2332, 1994.
10. Thorn M, Ponten F, Bergstrom R, et al: Clinical and histopathological predictors of survival in patients with malignant melanoma: a population-based study in Sweden. J Natl Cancer Inst 86:761-769, 1994.
11. Breslow A: Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma. Ann Surg 172:902-908, 1970.
12. Slingluff CL Jr, Dodge RK, Stanley WE, Seigler HF: The annual risk of melanoma progression. Cancer 70:1917-1927, 1992.
13. Malignant melanoma of the skin (excluding eyelid). In Beahrs OH, Henson DE. Hutter RV et al. (eds): "American Joint Committee on Cancer Manual for Staging of Cancer." 4th ed. Philadelphia: Lippincott, 143-148, 1992.
14. NIH Consensus conference. Diagnosis and treatment of early melanoma. JAMA 268:1314-1319, 1992.
15. Handley WS: The pathology of melanotic growths in relation to their operative treatment. Lecture I. Lancet 1:927-933, 1907.
16. Handley WS: The pathology of melanotic growths in relation to their operative treatment. Lecture II. Lancet 1:966-1003, 1907.
17. Balch CM, Murad TM, Soong SJ, et al: Tumor thickness as a guide to surgical management of clinical stage 1 melanoma patients. Cancer 43: 883-888, 1979.
18. Day CL Jr. Mihm TM, Sober AJ. et al: Narrower margins for clinical stage 1 malignant melanoma. N Engl J Med 306:479-482, 1982.
19. Zeitels J, LaRossa D, Hamilton R, et al: A comparison of local recurrence and resection margins for stage I primary cutaneous malignant melanomas. Plast Reconstr Surg 81:688-693, 1988.
20. Wong CK: A study of melanocytes in the normal skin surrounding malignant melanoma. Dermatologica 141:215-225, 1970.
21. Malignant melanoma margins [letter]. N Engl J Med 307:439-440, 1982.
22. Balch CM, Karakousis C, Mertlin C, et al: Management of cutaneous melanoma in the United States. Surg Gynecol Obstet 158:311-318, 1984.
23. Veronesi U, Cascinelli N: Narrow excision ( 1-cm margin). A safe procedure for thin cutaneous melanoma. Arch Surg 126:438-441, 1991.
24. Balch CM, Urist MM, Karakousis CP. et al: Efficacy of 2-cm margins for intermediate-thickness melanomas ( 1 to 4 mm). Results of a multi-institutional randomized surgical trial. Ann Surg 218: 262-269, 1993.
25. Kenady DE, Brown BW, McBride CM: Excision of underlying fascia with a primary malignant melanoma: effect on recurrence and survival rates. Surgery 92:615-618, 1982.
26. O'Rourke MG, Altman CR: Melanoma recurrence after excision. Is a wide margin justified? Ann Surg 217:2-5, 1993.
27. Urist MM, Balch CM, Soong SJ, et al: Head and neck melanoma in 534 clinical stage I patients. A prognostic factors analysis and results of surgical treatment. Ann Surg 200:769-775, 1984.
28. Cohen LM: Lentigo maligna and lentigo maligna melanoma. J Am Acad Dermatol 33:923-936, 1995.
29. Heaton KM, el-Naggar A, Ensign LG. et al: Surgical management and prognostic factors in patients with subungual melanoma. Ann Surg 219:197-204, 1994.
30. Crombie IK: Racial differences in melanoma incidence. Br J Cancer 40:185-193, 1979.
31. Coleman WP 3rd, Loria PR, Reed RJ, Krementz ET: Acral lentiginous melanoma. Arch Dermatol 116:773-776, 1980.
32. Fortin PT, Freiberg AA, Rees R, et al.: Malignant melanoma of the foot and ankle. J Bone Joint Surg Am 77:1396-1403, 1995.
33. Alexander HR, Fraker DL, Bartlett DL: Isolated limb perfusion for malignant melanoma. Semin Surg Oncol 12:416-428, 1996.